Compare, Analyse Sun Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs MYLAN (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   MYLAN
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
MYLAN
Dec-18
SUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4843,547-   
Low Rs3151,952-   
Sales per share (Unadj.) Rs136.91,632.0-  
Earnings per share (Unadj.) Rs17.544.3-  
Cash flow per share (Unadj.) Rs26.0349.9-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.71,765.5-  
Shares outstanding (eoy) m2,399.26514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.7 173.3%   
Avg P/E ratio x22.962.0 36.9%  
P/CF ratio (eoy) x15.47.9 195.6%  
Price / Book Value ratio x2.11.6 136.0%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,8641,414,576 67.8%   
No. of employees `00017.835.0 50.7%   
Total wages/salary Rs m63,6240-   
Avg. sales/employee Rs Th18,490.623,990.1 77.1%   
Avg. wages/employee Rs Th3,582.60-   
Avg. net profit/employee Rs Th2,357.6651.4 361.9%   
INCOME DATA
Net Sales Rs m328,375839,653 39.1%  
Other income Rs m6,3600-   
Total revenues Rs m334,735839,653 39.9%   
Gross profit Rs m69,898217,271 32.2%  
Depreciation Rs m20,528157,216 13.1%   
Interest Rs m3,02740,384 7.5%   
Profit before tax Rs m52,70219,671 267.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,6060-   
Tax Rs m8,228-3,129 -262.9%   
Profit after tax Rs m41,86822,800 183.6%  
Gross profit margin %21.325.9 82.3%  
Effective tax rate %15.6-15.9 -98.1%   
Net profit margin %12.82.7 469.5%  
BALANCE SHEET DATA
Current assets Rs m316,542468,862 67.5%   
Current liabilities Rs m157,064341,852 45.9%   
Net working cap to sales %48.615.1 321.1%  
Current ratio x2.01.4 146.9%  
Inventory Days Days8884 104.7%  
Debtors Days Days10593 112.2%  
Net fixed assets Rs m243,102162,879 149.3%   
Share capital Rs m2,399447 536.7%   
"Free" reserves Rs m450,2450-   
Net worth Rs m452,645908,351 49.8%   
Long term debt Rs m20,289980,403 2.1%   
Total assets Rs m682,5252,436,552 28.0%  
Interest coverage x18.41.5 1,237.9%   
Debt to equity ratio x01.1 4.2%  
Sales to assets ratio x0.50.3 139.6%   
Return on assets %6.62.6 253.7%  
Return on equity %9.22.5 368.5%  
Return on capital %11.23.2 353.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m46,2550-   
CASH FLOW
From Operations Rs m65,548174,480 37.6%  
From Investments Rs m-25,888-90,187 28.7%  
From Financial Activity Rs m-57,151-81,283 70.3%  
Net Cashflow Rs m-13,8571,445 -958.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.51 Rs / USD

Compare SUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: FULFORD INDIA  CADILA HEALTHCARE  AJANTA PHARMA  ELDER PHARMA  ABBOTT INDIA  



Today's Market

6 Reasons Behind the Stock Market Crash, HDFC Bank Q4FY21 Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets nosedived and registered sharp losses in yesterday's volatile session following a strong second wave of Covid-19 in the country.

Related Views On News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


Apr 19, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS